13/10/2026
The HSE Emerging Drug Trends Laboratory have identified the novel benzodiazepine meclonazepam sold as alprazolam in counterfeit benzodiazepines in the Dublin region (Tallaght and Dublin 8). These product have been linked with strong effects, severe sedation and overdose. We are also monitoring benzodiazepine overdoses occurring in the Mid-West last week, with cases subject to substance analysis.
Meclonazepam is circulating in two types of blister packets, one has distinctive orange packaging.
How to use this information:
· Inform people who use: Please use this update to inform local interventions
· Monitor and obtain further information about this and other new products to the market
Addiction, health, and social care services are asked to please report to the HSE Emerging Drug Trends and Early Warning System by contacting [email protected] if you encounter these products in your area, if there is an increases in overdoses associated with these products, and/or if new products causing concern at your addiction service.